Blog examines future of European Union aid

NewsGuard 100/100 Score

In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Elisa Baldini, an advocacy and campaigns officer with Plan E.U., examines the future of European Union aid, writing, "Last week, European Union leaders came together for a decisive summit to discuss how much they think the E.U. should spend from 2014-2020, and what they should spend the budget on." She continues, "As a result of last week's summit, Heading 4 (Global Europe) and the European Development Fund (EDF) have been cut by 16 percent and 11 percent respectively, compared with the European Commission's original proposal," adding, "What that means in real terms -- that is, compared with the current situation for 2007-2013 -- is that the level of development aid has been frozen" (2/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New peptide library paves the way for targeting elusive cancer factor MYC